VPC12249 [Ligand Id: 2909] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL327240
  • LPA1 receptor/Lysophosphatidic acid receptor Edg-2 in Human [ChEMBL: CHEMBL3819] [GtoPdb: 272] [UniProtKB: Q92633]
  • LPA1 receptor in Mouse [GtoPdb: 272] [UniProtKB: P61793]
There should be some charts here, you may need to enable JavaScript!
  • LPA3 receptor/Lysophosphatidic acid receptor Edg-7 in Human [ChEMBL: CHEMBL3250] [GtoPdb: 274] [UniProtKB: Q9UBY5]
There should be some charts here, you may need to enable JavaScript!
  • S1P3 receptor in Human [GtoPdb: 277] [UniProtKB: Q99500]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
LPA1 receptor/Lysophosphatidic acid receptor Edg-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3819] [GtoPdb: 272] [UniProtKB: Q92633]
ChEMBL In vitro ability to antagonize LPA-evoked [35S]GTP-gamma-S binding to lysophosphatidic acid receptor 1 in HEK293T cell lines F 5.6 pIC50 2490 nM IC50 Bioorg Med Chem Lett (2004) 14: 2735-2740 [PMID:15125924]
LPA1 receptor in Mouse [GtoPdb: 272] [UniProtKB: P61793]
GtoPdb - - 6.86 pKi 137 nM Ki Mol Pharmacol (2001) 60: 1173-80 [PMID:11723223]
LPA3 receptor/Lysophosphatidic acid receptor Edg-7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3250] [GtoPdb: 274] [UniProtKB: Q9UBY5]
GtoPdb - - 6.37 pKi - - - Mol Pharmacol (2001) 60: 1173-80 [PMID:11723223]
ChEMBL In vitro antagonism of LPA-evoked [35S]GTP-gamma-S binding to lysophosphatidic acid receptor 3 in HEK293T cell lines F 5 pIC50 >10000 nM IC50 Bioorg Med Chem Lett (2004) 14: 2735-2740 [PMID:15125924]
GtoPdb - - 6.37 pIC50 428 nM IC50 Curr Med Chem (2008) 15: 2122-31 [PMID:18781939];
Mol Pharmacol (2001) 60: 1173-80 [PMID:11723223]
S1P3 receptor in Human [GtoPdb: 277] [UniProtKB: Q99500]
GtoPdb - - 6.5 pEC50 - - - Bioorg Med Chem (2007) 15: 663-77 [PMID:17113298]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]